IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.336
NA - Nord America 1.982
EU - Europa 927
SA - Sud America 293
AF - Africa 53
OC - Oceania 28
Totale 15.619
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 10.201
US - Stati Uniti d'America 1.869
CN - Cina 1.010
HK - Hong Kong 786
GB - Regno Unito 250
BR - Brasile 220
IT - Italia 197
DE - Germania 150
VN - Vietnam 147
CA - Canada 68
IN - India 58
FI - Finlandia 55
NL - Olanda 46
PL - Polonia 38
MX - Messico 32
TR - Turchia 31
FR - Francia 29
ES - Italia 27
AR - Argentina 26
AU - Australia 26
CZ - Repubblica Ceca 25
ZA - Sudafrica 25
RU - Federazione Russa 22
UA - Ucraina 22
ID - Indonesia 19
EC - Ecuador 18
JP - Giappone 15
CH - Svizzera 11
CL - Cile 10
SE - Svezia 9
BD - Bangladesh 8
SA - Arabia Saudita 7
BE - Belgio 6
PY - Paraguay 6
AT - Austria 5
BY - Bielorussia 5
DK - Danimarca 5
LT - Lituania 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
CO - Colombia 4
MA - Marocco 4
UY - Uruguay 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
IQ - Iraq 3
IR - Iran 3
LB - Libano 3
MY - Malesia 3
TH - Thailandia 3
BH - Bahrain 2
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
HT - Haiti 2
HU - Ungheria 2
IE - Irlanda 2
IS - Islanda 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
MW - Malawi 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
VE - Venezuela 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
MS - Montserrat 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
Totale 15.608
Salva come PNG Salva come JPEG
Città #
Hong Kong 769
Singapore 707
Hefei 494
Ashburn 406
Boardman 264
Dallas 221
London 203
Shanghai 190
Beijing 148
Munich 87
Rome 79
Los Angeles 74
Council Bluffs 67
San Francisco 61
Ho Chi Minh City 59
West Jordan 41
Seattle 39
Toronto 38
Warsaw 36
São Paulo 34
Turku 34
Santa Clara 33
Pune 32
Washington 31
Amsterdam 25
New York 25
Brno 22
Mexico City 22
Hanoi 21
Helsinki 21
Sona 20
Brooklyn 19
Boston 17
Montreal 16
Atlanta 13
Johannesburg 13
Guangzhou 12
Tokyo 12
Central 11
Melbourne 11
Chennai 10
Chicago 10
Manchester 10
Paris 10
Rio de Janeiro 10
Canberra 9
Milan 9
Charlotte 8
Da Nang 8
Stockholm 8
Guayaquil 7
Haiphong 7
Thái Bình 7
Ankara 6
Brasília 6
Frankfurt am Main 6
Haikou 6
Moscow 6
Redmond 6
Riyadh 6
Curitiba 5
Jinan 5
Poplar 5
Secaucus 5
Zhengzhou 5
Berlin 4
Bắc Giang 4
Campinas 4
Copenhagen 4
Denver 4
Hanover 4
Naples 4
Phoenix 4
Quito 4
Sydney 4
The Dalles 4
Thái Nguyên 4
Vienna 4
Bangkok 3
Belo Horizonte 3
Bologna 3
Brownsville 3
Buenos Aires 3
Buffalo 3
Camden 3
Chengdu 3
Delhi 3
Ha Long 3
Handan 3
Jackson 3
Kyiv 3
Minsk 3
Montevideo 3
Nam Định 3
Nanyang 3
Newark 3
Oklahoma City 3
Olomouc 3
Orem 3
Pamplona 3
Totale 4.725
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 221
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 205
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 203
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 201
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 199
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 198
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 198
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 198
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 196
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 194
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 192
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 192
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 191
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 190
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 190
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 189
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 189
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 187
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 187
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 187
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 186
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 185
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 182
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 179
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 179
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 178
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 177
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 177
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 176
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 173
Assessment of liver function by the exhaled breath-print during chronic liver disease 173
Blood glucose monitoring in the normal population: the PREDICA study 171
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 171
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 168
[Hepatocarcinoma: from epidemiology to gene therapy] 168
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 162
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 158
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 134
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 108
GH-resistance in different stages of chronic liver disease 108
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 107
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 104
Enhanced portal flow velocity and volume following Iloprost treatment 103
Diabetes in chronic liver disease: from old concepts to new evidence 103
Anestesia e malattie non comuni 102
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 101
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 99
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 98
[A 73-year-old woman with vomiting and metabolic alkalosis] 98
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 97
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 97
Radiofrequency ablation of hepatic tissue: a new experimental animal model 96
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 94
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 94
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 93
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 93
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 92
A challenging alfa-fetoprotein in a cirrhotic patient 91
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 90
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 89
Anesthesia & uncommon diseases 89
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 88
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 87
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 87
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 87
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 86
[A 61-year-old woman with abdominal pain and urination disorders] 86
[A 74-year-old woman with macrocytic anemia] 86
Breathprinting of liver diseases 86
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 85
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 85
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 84
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 81
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 81
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 81
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 80
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 80
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 79
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 79
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 78
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 77
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 77
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 76
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 72
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 71
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 70
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 68
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 65
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 64
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 61
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 58
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 56
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 53
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 49
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 48
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 46
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 45
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates 44
Pain and Frailty in Hospitalized Older Adults 42
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 42
Totale 12.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20262.122 773 390 548 411 0 0 0 0 0 0 0 0
Totale 15.691